HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Riu Hamada Selected Research

M-VAC protocol

8/2011The efficacy and safety of gemcitabine plus cisplatin regimen for patients with advanced urothelial carcinoma after failure of M-VAC regimen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Riu Hamada Research Topics

Disease

2Prostatic Neoplasms (Prostate Cancer)
06/2016 - 07/2010
1Neoplasms (Cancer)
01/2015
1Margins of Excision
01/2015
1Fever (Fevers)
02/2012
1Neoplasm Metastasis (Metastasis)
08/2011
1Carcinoma (Carcinomatosis)
08/2011
1Pathologic Constriction (Stenosis)
05/2009
1Urinary Retention
05/2009

Drug/Important Bio-Agent (IBA)

1ABO Blood-Group SystemIBA
01/2015
1Blood Group Antigens (Blood Groups)IBA
01/2015
1Anti-Bacterial Agents (Antibiotics)IBA
02/2012
1Cisplatin (Platino)FDA LinkGeneric
08/2011
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2011
1Methotrexate (Mexate)FDA LinkGeneric
08/2011
1Hemoglobins (Hemoglobin)IBA
08/2011
1GemcitabineFDA Link
08/2011
1EstramustineFDA Link
07/2010
1Docetaxel (Taxotere)FDA Link
07/2010
1Hormones (Hormone)IBA
07/2010
1Hydrocortisone (Cortisol)FDA LinkGeneric
07/2010
1Phosphates (Orthophosphate)IBA
07/2010

Therapy/Procedure

1Prostatectomy (Retropubic Prostatectomy)
06/2016
1Drug Therapy (Chemotherapy)
08/2011
1M-VAC protocol
08/2011
1Combination Drug Therapy (Combination Chemotherapy)
08/2011
1Catheters
05/2009